Skip to main navigation
  • Home
  • Pipeline
  • Team
  • Research
  • News
  • Investors
  • Careers
  • Contact
Go to Seaport Therapeutics Corporate Home
  • Home
  • Pipeline
  • Team
  • Research
  • News
  • Investors
  • Careers
  • Contact

SEC Filing Details

  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Board of Directors
    • Management Team
    • Committee Composition
  • Financial Information
    • SEC Filings
  • IR Resources
    • Email Alerts
    • Contact Us

Document Details

Form
8-K
Filing Date
May 4, 2026
Document Date
May 4, 2026
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Seaport Therapeutics
Issuer
SEAPORT THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
Seaport Therapeutics Logo
Seaport Therapeutics
101 Seaport Blvd, Floor 12
Seaport Boston, MA 02210

info@seaporttx.com


Privacy Policy
Terms of Use

© 2026 Seaport Therapeutics

Seaport Therapeutics Logo

Seaport Therapeutics
101 Seaport Blvd, Floor 12
Seaport Boston, MA 02210

info@seaporttx.com

Privacy Policy | Terms of Use | Expanded Access Policy

Privacy Policy | Terms of Use | Expanded Access Policy

Privacy Policy | Terms of Use | Expanded Access Policy

© 2026 Seaport Therapeutics

Privacy Policy | Terms of Use | Expanded Access Policy

© 2026 Seaport Therapeutics

Search Investors